News

FDA approves expanded use of Moderna’s RSV shot, but uncertainty remains
The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to ...
Celebrated, then disparaged: mRNA’s promise is tarnished under Trump
The promise of mRNA technology seemed boundless after the success of the coronavirus vaccines, but Robert F. Kennedy Jr. has ...
RFK Jr.’s new vaccine advisers include ER doctor who posted Islamophobic commentary online, expert witnesses against vaccines
Among the eight people who Robert F. Kennedy Jr. announced would make up his new group of outside vaccine advisers to the US Centers for Disease Control and Prevention are an emergency physician who ...
Fact check: HHS misleads on mRNA vaccine safety after pulling Moderna funding
The safety of approved mRNA vaccines is well-established and, as with other vaccines, continues to be monitored by multiple ...
FDA expands approval of Moderna's RSV vaccine to some adults under age 60
The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the ...
BioPharma Dive2d
Moderna wins FDA OK to widen use of RSV vaccine
The agency’s decision to clear Moderna’s shot for use in certain younger adults is a much-needed win for a company that’s ...
Infectious Disease Advisor2d
FDA Alert: Infectious Diseases Drug News Roundup
FDA drug alerts in infectious diseases, including new drug approvals, safety warnings, recalls, and changes in indications.
MedPage Today2d
U.K.: Toss Candy Over Cancer Risk; Ban TV Pharma Ads? 'Our Brains Stopped Working'
Note that some links may require registration or subscription. The United Kingdom's Food Standards Agency says that certain ...
Moderna falls on doubts over new CDC panel's backing of RSV vaccine
The mRNA-based RSV shot, mRESVIA, secured U.S. approval on Thursday for use in at-risk adults aged 18 to 59 years, but needs ...
Moderna falls on fears new CDC vaccine advisory panel could cloud RSV shot prospects
Moderna's shares fell 2.5% before the bell on Friday, on concerns whether a new CDC advisory panel would back the use of the ...
FDA expands Moderna's RSV vaccine approval to at-risk adults
The U.S. Food and Drug Administration has approved Moderna’s (MRNA) RSV vaccine, mRESVIA (mRNA-1345), for preventing lower respiratory tract disease in adults aged 18 to 59 ...